Application and Impact Assessment of Ultrasound Super-Resolution Blood Flow Imaging (URM) in Patients With Renal Failure

Status

Completed

Phases

Unknown

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT07484308

Acronym

URM

Enrollment

150

Registered

2026-03-20

Start date

2024-10-01

Completion date

2026-03-01

Last updated

2026-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Failure

Keywords

URM, Kidney failure

Brief summary

The aim of this study is to evaluate the utility of URM technology in imaging renal microcirculatory blood flow in patients with renal failure, and to investigate its clinical feasibility for assessing renal function, disease staging and monitoring treatment response.

Interventions

DIAGNOSTIC_TESTUltrasound super-resolution blood flow imaging

The primary objective is to examine the correlation between URM parameters (renal cortical and medullary microvascular density, blood flow velocity) and laboratory markers of renal function (eGFR, Scr)

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

NONE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

① Clinically diagnosed with acute or chronic renal failure; ② Complete laboratory test results and ultrasound images are available.

Exclusion criteria

① Concurrent severe organ failure; ② Poor image quality; ③ History of renal surgery; ④ Pregnant or breastfeeding women.

Design outcomes

Primary

Measure	Time frame
Correlation between URM parameters (renal cortical and medullary microvascular density, blood flow velocity) and laboratory renal function markers (eGFR, Scr)	From enrollment to the end of treatment at 14 days

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 21, 2026